Soc. Generale Knock-Out BEI 21.06.../ DE000SU63VV5 /
16/05/2024 10:31:23 | Var.+0.39 | Denaro14:06:31 | Lettera14:06:31 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
9.80EUR | +4.14% | 9.34 Quantità in denaro: 10,000 |
9.54 Quantità in lettera: 10,000 |
BEIERSDORF AG O.N. | - EUR | 21/06/2024 | Call |
GlobeNewswire
14:15
Hip-Hop Duo Flyana Boss Joins Musicians On Call & Men’s Wearhouse in Making Prom Memories With Pedia...
GlobeNewswire
14:15
Claritas HealthTech Extends Claritas iPET™ capability with iPETcertum™ for Automated Lesion Detectio...
GlobeNewswire
14:15
Imperial Petroleum Inc. Reports First Quarter 2024 Financial and Operating Results
GlobeNewswire
14:05
LED Lighting and EV Charging Solutions Provider Orion Previews FY 2024 Results in Anticipation of it...
GlobeNewswire
14:05
MatrixCare Joins Health Gorilla’s Qualified Health Information Network (QHIN) to Enhance Patient Dat...
GlobeNewswire
14:05
NKGen Biotech Announces Upcoming Presentation on Autologous NK Cell Therapy at the 5th International...
GlobeNewswire
14:03
Meltwater Integrates Influencer Marketing Analytics, Workflows Within Social Suite, in an Industry F...
GlobeNewswire
14:01
Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
GlobeNewswire
14:01
Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Patent Allowance for Malaria Antibodies That Have Po...
GlobeNewswire
14:00
Fortress Biotech to Participate in the Alliance Global Partners’ (A.G.P.) Virtual Healthcare Company...
GlobeNewswire
14:00
Allegro MicroSystems to Present at TD Cowen’s Technology, Media & Telecom Conference on May 29
GlobeNewswire
14:00
Oragenics, Inc. Prepares Intranasal Pharmaceutical, ONP-002, for Phase II Concussion Trial
GlobeNewswire
14:00
Akari Therapeutics Reports First Quarter 2024 Financial Results and Recent Highlights